BeOne Medicines (ONC) Tax Rate (2015 - 2026)
BeOne Medicines' (ONC) quarterly Tax Rate came in at 12.29% in Q1 2026, down 8163.0% year-on-year from 0.15% in Q1 2025, and down 77.83% on a QoQ basis from 55.44% in Q4 2025.
BeOne Medicines (ONC) Tax Rate (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has 12 years of Tax Rate data on file, last reported at 12.29% in Q1 2026.
- On a quarterly basis, Tax Rate fell 8163.0% year-over-year to 12.29% in Q1 2026; TTM through Mar 2026 was 21.7%, a 6773.0% increase from a year earlier, with the FY2025 full-year figure at 31.17%, up 5214.0% from the prior year.
- Tax Rate for Q1 2026 stood at 12.29%, down from 55.44% in the prior quarter.
- Over the last five years, Tax Rate for ONC reached as high as 93.92% in Q1 2025 and fell as low as 77.95% in Q4 2024.
- Historically, Tax Rate has averaged 2.87% across 5 years, with a median of 3.17% in 2024.
- Across the five-year window, Tax Rate surged 13339 bps in 2025 and tumbled 8163 bps in 2026, its largest moves.
- Year by year, Tax Rate stood at 3.33% in 2022, then slumped by 43 bps to 4.78% in 2023, then sank by 1529 bps to 77.95% in 2024, then surged by 171 bps to 55.44% in 2025, then sank by 78 bps to 12.29% in 2026.
- Per Business Quant data, the three most recent Tax Rate figures were 12.29% in Q1 2026, 55.44% in Q4 2025, and 15.17% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 7.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.29% |
| Mar 31, 2026 | 12.29% |
| Mar 31, 2026 | 12.29% |
| Dec 31, 2025 | 55.44% |
| Dec 31, 2025 | 55.44% |
| Dec 31, 2025 | 55.44% |
| Sep 30, 2025 | 15.17% |
| Sep 30, 2025 | 15.17% |
| Sep 30, 2025 | 15.17% |
| Jun 30, 2025 | 5.25% |
| Jun 30, 2025 | 5.25% |
| Jun 30, 2025 | 5.25% |
| Mar 31, 2025 | 93.92% |
| Mar 31, 2025 | 93.92% |
| Mar 31, 2025 | 93.92% |
| Dec 31, 2024 | -77.95% |
| Dec 31, 2024 | -77.95% |
| Dec 31, 2024 | -77.95% |
| Sep 30, 2024 | -23.44% |
| Sep 30, 2024 | -23.44% |